Our most recent episode of The Expert Series podcast “Your Lupus Treatment Roadmap: Understanding the New Guidelines and What They Mean for You” explores the newly released SLE treatment guidelines ...
Yale researchers have identified CD8+ T cells as a key driver of kidney damage in lupus, challenging the long-standing focus on B cells. The discovery may explain why some patients do not respond to ...
NEW YORK, Jan. 6, 2026 /PRNewswire/ -- Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the formation of a new philanthropic venture fund Lupus ...
Until biomarkers that can predict treatment response emerge, early and aggressive treatment is recommended in lupus nephritis ...
AstraZeneca’s SAPHNELO ® (anifrolumab-fnia) has been approved in the US for self-administration as a once-weekly autoinjector, the SAPHNELO Pen , for the treatment of adult patients with systemic ...
That’s what the autoimmune disease lupus does, 1 and when it strikes, it can cause significant symptoms, including extreme ...
Over three quarters of people on Gazyva plus standard therapy achieved at least a four-point improvement in SRI-4, a measure that assesses disease severity and symptoms Gazyva has the potential to ...
Brickell Rheumatology Wellness Center, based in Miami, Florida, announced an educational initiative focused on raising awareness about lupus medication side effects. The clinic aims to help patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results